HLD-0117

· Halda Therapeutics OpCo, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLD-0117, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HLD-0117 in Patients With Metastatic Breast Cancer [Phase 1]